AQR Capital Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,535
| Closed | -$10.6K | – | 2867 |
|
|
2024
Q2 | $10.6K | Sell |
29,535
-843
| -3% | -$302 | ﹤0.01% | 2586 |
|
|
2024
Q1 | $20.4K | Buy |
+30,378
| New | +$20.4K | ﹤0.01% | 2391 |
|
|
2021
Q1 | – | Sell |
-15,957
| Closed | -$249K | – | 2258 |
|
|
2020
Q4 | $249K | Buy |
+15,957
| New | +$249K | ﹤0.01% | 2027 |
|
|
2019
Q1 | – | Sell |
-11,551
| Closed | -$133K | – | 2211 |
|
|
2018
Q4 | $133K | Sell |
11,551
-39,231
| -77% | -$452K | ﹤0.01% | 2126 |
|
|
2018
Q3 | $861K | Sell |
50,782
-4,958
| -9% | -$84.1K | ﹤0.01% | 1757 |
|
|
2018
Q2 | $792K | Sell |
55,740
-9,996
| -15% | -$142K | ﹤0.01% | 1809 |
|
|
2018
Q1 | $1.25M | Buy |
65,736
+9,364
| +17% | +$178K | ﹤0.01% | 1580 |
|
|
2017
Q4 | $925K | Buy |
56,372
+3,471
| +7% | +$57K | ﹤0.01% | 1708 |
|
|
2017
Q3 | $794K | Buy |
+52,901
| New | +$794K | ﹤0.01% | 1753 |
|
|
2014
Q4 | – | Sell |
-55,742
| Closed | -$601K | – | 2614 |
|
|
2014
Q3 | $601K | Hold |
55,742
| – | – | ﹤0.01% | 1871 |
|
|
2014
Q2 | $851K | Hold |
55,742
| – | – | ﹤0.01% | 1723 |
|
|
2014
Q1 | $1.01M | Buy |
55,742
+700
| +1% | +$12.7K | ﹤0.01% | 1697 |
|
|
2013
Q4 | $765K | Sell |
55,042
-11,258
| -17% | -$156K | ﹤0.01% | 1859 |
|
|
2013
Q3 | $695K | Hold |
66,300
| – | – | ﹤0.01% | 1829 |
|
|
2013
Q2 | $518K | Buy |
+66,300
| New | +$518K | ﹤0.01% | 1871 |
|